Academic Council discussed a review of the University’s master’s programs, received nominations for its next chair and raised ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

Just in the past week, generative AI company Abridge announced deals with Mayo Clinic, Duke Health, and Johns Hopkins ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

Whether you want to expand your knowledge or fast-track your career, graduate school can be a great option. With advancements ...

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...

These contributions reflect the community’s strong support for Duke-NUS’ leading role in medical innovation and education.

Duke Health in Durham, N.C., has selected Abridge as its generative AI partner to capture clinical conversations.

Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and ...

One of the moments that Ms Jazreel Low, a fourth-year student from Duke-NUS’ Doctor of Medicine Programme, will never forget is seeing her name in the Journal of Translational Medicine ...